ReviewFrontiers in microbiology2017
Control of Antimicrobial Resistance Requires an Ethical Approach.
Review in Frontiers in microbiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
38 citing papers in PubMed.
- Reassessing Antibiotic Duration in Dental Infections: A Narrative Review and Marginal Benefit-Harm Framework with a Clinical Checklist.Antibiotics (Basel, Switzerland) · 2026Review
- Antimicrobial Resistance as a Global Public Health Challenge: Epidemiological Burden, Bioethical Dimensions and Emerging Therapeutic Strategies.Infectious disease reports · 2026Review
- Community engagement strategies for antimicrobial resistance control and interventions.BMJ public health · 2026Review
- National Action Plans for Antimicrobial Resistance in the WHO Western Pacific Region: The Just Transitions Lens.Public humanities · 2026Article
- Antibiotic resistance and preventive strategies in foodborne pathogenic bacteria: a comprehensive review.Food science and biotechnology · 2025Review
- End-of-Life Infections and the Dilemma of Emerging Antimicrobial Resistance: A Scoping Review.Infection & chemotherapy · 2025Review
- Antimicrobial Prescribing Patterns in GP Practices in Northern Ireland.Antibiotics (Basel, Switzerland) · 2024Article
- An Overview of the Recent Advances in Antimicrobial Resistance.Microorganisms · 2024Review
- One Health Ethics and the Ethics of Zoonoses: A Silent Call for Global Action.Veterinary sciences · 2024Review
- Time is running out. No excuses to delay implementation of antimicrobial stewardship programmes: impact, sustainability, resilience and efficiency through an interrupted time series analysis (2017-2022).JAC-antimicrobial resistance · 2024Article
- Attitudes of South Korean consumers toward the prudent use of antimicrobials in livestock animals.One health (Amsterdam, Netherlands) · 2024Article
- Antimicrobial stewardship in private pharmacies in Wakiso district, Uganda: a qualitative study.Journal of pharmaceutical policy and practice · 2023Article
- Multi-Criteria Decision Analysis for Assessing Social Acceptance of Strategies to Reduce Antimicrobial Use in the French Dairy Industry.Antibiotics (Basel, Switzerland) · 2022Article
- Implementation of antibiotic stewardship programmes in paediatric patients in regional referral hospitals in Tanzania: experience from prescribers and dispensers.JAC-antimicrobial resistance · 2022Article
- In critique of anthropocentrism: a more-than-human ethical framework for antimicrobial resistance.Medical humanities · 2022Review
- Self-Medication in Rural Northeastern Romania: Patients' Attitudes and Habits.International journal of environmental research and public health · 2022Article
- The New Precision Stewards?Journal of personalized medicine · 2022Article
- Perspectives on the Ethics of Antibiotic Overuse and on the Implementation of (New) Antibiotics.Infectious diseases and therapy · 2022Article
- Polish Medical Doctors' Opinions on Available Resources and Information Campaigns concerning Antibiotics and Antibiotic Resistance, a Cross-Sectional Study.Antibiotics (Basel, Switzerland) · 2022Article
- Antimicrobial Properties of TiOInternational journal of molecular sciences · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ethical behavior encompasses actions that benefit both self and society. This means that tackling antimicrobial resistance (AMR) becomes an ethical obligation, because the prospect of declining anti-infectives affects everyone. Without preventive action, loss of drugs that have saved lives over the past century, will condemn ourselves, people we know, and people we don't know, to unacceptable risk of untreatable infection. Policies aimed at extending antimicrobial life should be considered within an ethical framework, in order to balance the choice, range, and quality of drugs against stewardship activities. Conserving availability and effectiveness for future use should not compromise today's patients. Practices such as antimicrobial prophylaxis for healthy people 'at risk' should receive full debate. There are additional ethical considerations for AMR involving veterinary care, agriculture, and relevant bio-industries. Restrictions for farmers potentially threaten the quality and quantity of food production with economic consequences. Antibiotics for companion animals do not necessarily spare those used for humans. While low-income countries cannot afford much-needed drugs, pharmaceutical companies are reluctant to develop novel agents for short-term return only. Public demand encourages over-the-counter, internet, black market, and counterfeit drugs, all of which compromise international control. Prescribers themselves require educational support to balance therapeutic choice against collateral damage to both body and environment. Predicted mortality due to AMR provides justification for international co-operation, commitment and investment to support surveillance and stewardship along with development of novel antimicrobial drugs. Ethical arguments for, and against, control of antimicrobial resistance strategies are presented and discussed in this review.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.